Related Experiment Video

Updated: Feb 5, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
09:36

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

26.3K

BC200 (BCYRN1) - The shortest, long, non-coding RNA associated with cancer

J Samson1, S Cronin1, K Dean1

  • 1School of Biochemistry and Cell Biology, Western Gateway Building, University College Cork, Cork, Ireland.

Non-Coding RNA Research
|September 4, 2018
PubMed

Insights

Researchers explore the role of the long non-coding RNA BC200 (BCYRN1) in cancer. This review summarizes its functions in neuronal systems and its potential as a cancer biomarker or therapeutic target.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • The human transcriptome includes numerous non-coding RNAs with diverse biological functions.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cellular processes.
  • Aberrant lncRNA expression is implicated in various cancers, necessitating functional studies.

Purpose of the Study:

  • To review the known functions of BC200 (BCYRN1), a lncRNA originally identified in the brain.
  • To explore the contribution of BC200 to cancer initiation, progression, and metastasis.
  • To assess the potential of BC200 as a clinical biomarker or therapeutic target in cancer.

Main Methods:

  • Literature review of studies on BC200 in neuronal systems.
  • Analysis of recent research investigating BC200's role in cancer biology.
  • Evaluation of BC200's potential clinical applications.

Main Results:

  • BC200 is a predominantly cytoplasmic lncRNA linked to neurodegenerative diseases.
  • Emerging evidence suggests BC200's involvement in cancer development and spread.
  • BC200 exhibits potential as a biomarker and therapeutic target.

Conclusions:

  • BC200 plays a significant role in both neuronal function and cancer.
  • Further research into BC200's mechanisms in cancer is warranted.
  • BC200 holds promise for future cancer diagnostics and therapeutics.
Keywords:
BC200BCYRN1CancerLong non-coding RNARNA-protein interactionsTranslational regulationlncRNA

More Related Videos

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood09:40

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood

Published on: November 28, 2018

7.8K
Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification10:39

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification

Published on: November 28, 2016

11.8K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.7K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.7K
Ribosomal RNA Synthesis02:53

Ribosomal RNA Synthesis

Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
14.9K
Nursing Code of Ethics01:29

Nursing Code of Ethics

The Nursing Code of Ethics sets the ethical benchmark for the profession, and guides nurses in ethical analysis and decision making at the societal, organizational, and clinical levels. The code encompasses showing compassion and respect for the patient, their families, and communities in all circumstances while committing to providing patient-centered care. In addition, the code states that nurses must advocate for the patient by defending a cause or recommendation to protect their rights,...
4.6K
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
13.4K